NT-proBNP and Heart Disease in Diabetic Patients
Author Information
Author(s): Fang Zhou, Zhou Linuo, Bao Yuanyuan, Ding Wei, Shi Haiming, Luo Xinping, Hu Renming
Primary Institution: Huashan Hospital of Fudan University, Shanghai, China
Hypothesis
The study aims to determine whether plasma levels of NT-proBNP and other biomarkers change with the severity of coronary heart disease in diabetic and pre-diabetic patients.
Conclusion
Plasma NT-proBNP may be an important biomarker to evaluate the severity of coronary heart disease in diabetic or pre-diabetic patients.
Supporting Evidence
- Gensini scores increased with increasing biomarker tertile levels and HbA1c.
- NT-proBNP had the highest predictive values for coronary heart disease.
- Only NT-proBNP was identified as an independent variable for Gensini score.
Takeaway
This study found that a substance called NT-proBNP in the blood can help doctors understand how serious heart disease is in people with diabetes.
Methodology
The study involved 415 Chinese patients divided into groups based on diabetes status, with blood samples taken to measure various biomarkers and angiographic assessments performed.
Limitations
The study excluded patients with certain heart conditions, which may limit the generalizability of the findings.
Participant Demographics
The study included 415 consecutive Chinese patients, both symptomatic and asymptomatic, scheduled for coronary angiography.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website